Skip to main content
Caplight Logo









Valgen Medtech Co., Ltd.

Valgen Medtech Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttps://www.valgenmed.com/

Last Round

Series B

May 6, 2021

Est. Valuation

$1.43B

Total Funding Raised

$158M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Valgen Medtech Co., Ltd. is a medical device company that specializes in the research, development, and manufacturing of interventional treatment solutions for structural heart diseases, including mitral and tricuspid valve repair systems.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

interventional cardiologyminimally invasive surgerystructural heart diseasemitral valve repairtranscatheter deviceheart valve repairtricuspid valve repairmedtechcardiac surgery devicesmedical device manufacturercardiovascular interventionmitral clipinterventional consumablesballoon dilatation catheteratrial septal puncture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Valgen Medtech Co., Ltd. Comparables

Compare Valgen Medtech Co., Ltd. with similar companies based on industry and business-model similarity.

Valgen Medtech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shanghai Hanyu Medical Technology
93%
Jenscare Scientific Co Ltd
89%
Peijia Medical
86%

Valgen Medtech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 6, 2021
Series AApr 1, 2019

Valgen Medtech Co., Ltd. Investors

Notable investors and investment history

Valgen Medtech Co., Ltd. investors
InvestorRounds
DCP CapitalSeries B
BioTrack CapitalSeries A
Lake Bleu CapitalSeries B
Qiming Venture PartnersSeries A, Series B
HongShan Capital Group (HSG)Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 19, 2026

    Grew 56% QoQ, from 9 to 14 employees.

  • Jul 21, 2026

    Grew 33% QoQ, from 9 to 12 employees.

Valgen Medtech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Valgen Medtech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Valgen Medtech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range14
Year Founded2015
Last FundingMay 6, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?